These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22103968)

  • 1. Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03% dermatologic ointment.
    Sakarya Y; Sakarya R
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):94-6. PubMed ID: 22103968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study.
    Virtanen HM; Reitamo S; Kari M; Kari O
    Acta Ophthalmol Scand; 2006 Oct; 84(5):693-5. PubMed ID: 16965503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis.
    Kymionis GD; Goldman D; Ide T; Yoo SH
    Cornea; 2008 Feb; 27(2):228-9. PubMed ID: 18216583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.
    Joseph MA; Kaufman HE; Insler M
    Cornea; 2005 May; 24(4):417-20. PubMed ID: 15829797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical tacrolimus ointment for treatment of intractable atopic keratoconjunctivitis: a case report and review of the literature.
    García DP; Alperte JI; Cristóbal JA; Mateo Orobia AJ; Muro EM; Valyi Z; Del Rio BJ; Arnao MR
    Cornea; 2011 Apr; 30(4):462-5. PubMed ID: 20861732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus ointment in atopic blepharoconjunctivitis does not seem to elevate intraocular pressure.
    Remitz A; Virtanen HM; Reitamo S; Kari O
    Acta Ophthalmol; 2011 May; 89(3):e295-6. PubMed ID: 20064110
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis.
    Al-Amri AM
    Am J Ophthalmol; 2014 Feb; 157(2):280-6. PubMed ID: 24439439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study.
    Attas-Fox L; Barkana Y; Iskhakov V; Rayvich S; Gerber Y; Morad Y; Avni I; Zadok D
    Curr Eye Res; 2008 Jul; 33(7):545-9. PubMed ID: 18600486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases.
    Miyazaki D; Tominaga T; Kakimaru-Hasegawa A; Nagata Y; Hasegawa J; Inoue Y
    Ophthalmology; 2008 Jun; 115(6):988-992.e5. PubMed ID: 17900694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.
    Cheng AC; Yuen K; Chan W
    Cornea; 2006 Jun; 25(5):634; author reply 634. PubMed ID: 16783160
    [No Abstract]   [Full Text] [Related]  

  • 11. [FK 506 ointment 0.1 % - A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients].
    Mayer K; Reinhard T; Reis A; Böhringer D; Sundmacher R
    Klin Monbl Augenheilkd; 2001 Nov; 218(11):733-6. PubMed ID: 11731901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical tacrolimus treatment of atopic eyelid disease.
    Rikkers SM; Holland GN; Drayton GE; Michel FK; Torres MF; Takahashi S
    Am J Ophthalmol; 2003 Mar; 135(3):297-302. PubMed ID: 12614745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus Ointment for Refractory Posterior Blepharitis.
    Sakassegawa-Naves FE; Ricci HMM; Moscovici BK; Miyamoto DA; Chiacchio BB; Holzchuh R; Santo RM; Hida RY
    Curr Eye Res; 2017 Nov; 42(11):1440-1444. PubMed ID: 28922018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.
    Liu FY; Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus ointment 0.03% for treatment of refractory childhood phlyctenular keratoconjunctivitis.
    Kymionis GD; Kankariya VP; Kontadakis GA
    Cornea; 2012 Aug; 31(8):950-2. PubMed ID: 22525784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.
    Tzu JH; Utine CA; Stern ME; Akpek EK
    Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atopic dermatitis management with tacrolimus ointment (Protopic).
    Kapp A; Allen BR; Reitamo S
    J Dermatolog Treat; 2003; 14(Suppl 1):5-16. PubMed ID: 14522634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis.
    Nivenius E; van der Ploeg I; Jung K; Chryssanthou E; van Hage M; Montan PG
    Eye (Lond); 2007 Jul; 21(7):968-75. PubMed ID: 16680103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.